WebbWe deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Shape … Webb24 aug. 2024 · SEATTLE, Aug. 24, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX), a biotechnology company developing RNA technologies to shape the future …
Full article: Advances in gold nanoparticle technology as a tool for ...
WebbDrug Discovery and Development Webb5 apr. 2024 · 简介:Shape Therapeutics是一家RNA编辑基因疗法开发商,Shape Therapeutics的平台包括专有的ShapeTx RNAfix ™技术,这项技术可通过利用诸如作用于RNA的腺苷脱氨酶(ADAR)、抑制性tRNA以及工程化的腺相关病毒(AAV)等蛋白质,直接在体内靶向和修饰RNA。 RNAfix™平台通过使用天然人类细胞修饰RNA,从而限制了 … run the race finish well
Shape Therapeutics Secures $112 Million in Series B Financing to ...
Webb11 apr. 2024 · In the gene therapy deal with Roche, ShapeTherapeutics will conduct preclinical research to identify and deliver development candidates discovered by its AI-powered platforms RNAfix™ and, potentially, AAVid.™ Shape Therapeutics is eligible to receive an initial payment as well as development, regulatory, and sales milestones … WebbShape Therapeutics to Present Data Highlighting Advances in Its AI-Driven RNA Technology Platforms at the 2024 ASGCT Annual Meeting Details: The data to be … Webb25 aug. 2024 · On August 24th, Swiss pharma giant Roche announced that it will collaborate with Shape Therapeutics, a Seattle-based biotech specializing in RNA editing technology. The deal, which could exceed $3 billion in value, aims to bring new treatments for neurodegenerative disorders and rare diseases from bench to bedside. run the race finish the course